Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Get alerts for new trials in your area by subscribing now
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Toronto, Pittsburgh PA, Ann Arbor MI, Columbus OH,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase 2, Recruiting
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
for
Cardiogenic Shock, Acute Myocardial Infarction
Location: Toronto, Falls Church VA, Weston FL
Sponsor: STAVROS G DRAKOS
Sex: All
Age: 18+
Code: NCT05185492
Recruiting
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
for
Eosinophilic Granulomatosis With Polyangiitis,
Location: Hamilton
Sponsor: University of Pennsylvania
Sex: All
Age: 0+
Code: NCT00315380
Recruiting
Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure
for
Heart Failure, Heart Failure, Systolic,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05008692
Recruiting
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
for
Prostate Metastases
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18 - 70+
Code: NCT05656794
Phase 2, Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Toronto, London, Syracuse NY, Danville PA, Ann Arbor MI,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase 3, Recruiting
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
for
Type 2 Diabetes Mellitus
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT04535960
Phase 2, Recruiting
Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease